United Kingdom Assisted Reproductive Technology Market Insight
The United Kingdom Assisted Reproductive Technology Market is growing at an 15.9%CAGR, driven by infertility, delayed parenthood, NHS access, and advances in IVF, ICSI, and embryo freezing.
United Kingdom Assisted Reproductive Technology Market Insights Forecasts to 2035
- The United Kingdom Assisted Reproductive Technology Market Size Was Estimated at USD 1084.4Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 15.9% from 2025 to 2035
- The United Kingdom Assisted Reproductive Technology Market Size is Expected to Reach USD 4744.6Million by 2035
Notable Insights for United Kingdom Assisted Reproductive Technology Market
- By treatment type, IVF dominated, accounting for approximately 55–60% share in 2024, driven by high success rates and widespread clinical adoption.
- By procedure type, fresh embryo transfer held approximately 50–55% share, due to better implantation outcomes in many patient groups.
- Approximately 1 in 6 UK couples experience fertility issues, increasing demand for assisted reproductive procedures nationwide.
- Around 60–70% of ART treatments in the UK are performed in private fertility clinics due to faster access and advanced technologies.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Assisted Reproductive TechnologyMarket, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Assisted Reproductive Technology Market
- Care Fertility
- IVF Hammersmith
- Bourn Hall Clinic
- CARE Fertility Group
- NHS Fertility Services
- IVF Spain
- Others
Recent Developments:
- In July 2025, Newcastle Fertility Centre reported eight UK babies born using mitochondrial donation IVF, preventing inherited mitochondrial diseases through advanced “three-parent” reproductive technology.
- In May 2025, University of Dundee launched a world-first MSc in IVF and Assisted Reproductive Technology with AI, training embryologists in advanced digital and automated fertility tools.
- In March 2025, Astorg launched Nexpring Health, a global MedTech firm consolidating ART suppliers including Hamilton Thorne and Cook Medical, improving IVF technology access and fertility lab innovation.
Market Segmentation:
United Kingdom Assisted Reproductive Technology Market, By Treatment Type
- In Vitro Fertilization (IVF)
- Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination (IUI)
- Others
United Kingdom Assisted Reproductive Technology Market, By Procedure Type
- Fresh Embryo Transfer
- Frozen Embryo Transfer
- Donor Egg/Sperm Cycles
- Others
United Kingdom Assisted Reproductive Technology Market, By End User
- Fertility Clinics
- Hospitals
- Research Centers
United Kingdom Assisted Reproductive Technology Market, By Distribution Channel
- Private Clinics
- Public Healthcare (NHS)
- Specialized Fertility Centers
Expert Views:
The UK Assisted Reproductive Technology Market is expected to grow steadily due to increasing infertility rates, lifestyle changes, and delayed parenthood trends. Experts highlight IVF as the dominant procedure, supported by continuous improvements in embryo selection and cryopreservation technologies. Rising adoption of AI-based fertility solutions and expanding private clinic networks are expected to enhance treatment success rates and drive market growth through 2035.